NEW YORK (GenomeWeb News) – ChromoTek today announced it has signed a contract with Bulldog Bio to distribute ChromoTek's entire line of affinity reagents in the US and Canada.

Portsmouth, NH-based Bulldog will sell and support ChromoTek's line of novel tools for protein and cell biology. Financial and other terms were not disclosed.

ChromoTek is based in Planegg-Martinsried, Germany and offers immunologic research tools derived from single domain alpaca antibodies for cell biology and proteomics. The company is a spinout of the Ludwig-Maximilians University Munich.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.